United States: Health authorities have highlighted that COVID-19 infection can now lead to a loss of sleep, according to a new study. The researchers have claimed that even a mild infection could lead to insomnia.
It is noteworthy that sleeplessness or sleep-derived nights could be reported among hospitalized COVID-19 patients. However, a new study conducted by researchers in Vietnam focused on the possible link between mild COVID-19 infection and sleep.
What ideology was followed while conducting the study?
While conducting the research, around 1,000 adults who tested positive for COVID-19 but were not admitted to the hospital were examined by the experts. Following the study, it was concluded that approximately 76 percent of the people complained about experiencing insomnia.
Out of the total, around 23 percent of the people mentioned that symptoms were severe while they were infected with COVID-19.
In addition to this, a third of the people who participated in the study complained about worse sleep quality, shorter duration of sleep, and difficulty falling asleep. Furthermore, half of the participants outlined that they saw a disturbed sleep pattern as they started waking up during the night.
Additionally, people with anxiety and depression also complain about disrupted sleep.
COVID-19 cases in the USA!
The Centers for Disease Control and Prevention (CDC) has underlined that the most dominant variant is JN.1, which has been responsible for around 93.1 percent of infections. The major reason behind the rapid spread is a high mutation of the strain.
The agency noted, during the weekly report, “Several key indicators are showing decreasing levels of activity nationally,” according to CBS News.
Further, the CDC’s tally through February 1 revealed that the virus is on the rise in the wastewater in the Southern region of the nation. It is to be noted that some regions of the nation are also witnessing steep slowdowns in the cases – which were diagnosed in the emergency rooms.
The organization released fresh information on Thursday from its pharmacy testing initiative, indicating that the recently modified COVID-19 vaccines for this season demonstrated 49% effectiveness in preventing symptomatic JN.1 infection among individuals who received their shot within the last two to four months.
“New data from CDC show that the updated COVID-19 vaccines were effective against COVID-19 during September 2023 – January 2024, including against variants from the XBB lineage, which is included in the updated vaccine, and JN.1, a new variant that has become dominant in recent weeks,” the CDC said in a post on Thursday, as per CBS News.